- Cell culture media, essential for the growth and maintenance of cells in laboratory settings, are increasingly critical components in biomedical research, vaccine production, and biopharmaceutical manufacturing across countries in the Middle East and Africa due to expanding healthcare capabilities and a rising focus on life sciences innovation
- The growing demand for cell culture media is primarily driven by the rising prevalence of chronic diseases, increasing investments in biotechnology research, and a surge in academic and clinical research initiatives targeting precision medicine and regenerative therapies
- Saudi Arabia dominated the Middle East and Africa cell culture media market with the largest revenue share of 39.2% in 2024, supported by favorable government policies, enhanced R&D funding, and the presence of advanced research centers. The Kingdom is leading regional growth through biotechnology hubs such as the King Abdullah International Medical Research Center and collaborations with international players
- South Africa is expected to be the fastest growing country in the Middle East and Africa cell culture media market during the forecast period due to increasing public and private sector initiatives in biomedical research and expanding pharmaceutical manufacturing capabilities
- The serum-free media segment dominated the Middle East and Africa cell culture media market with a share of 42% in 2024, driven by its suitability for standardized and contamination-free cell culture processes essential in clinical-grade biomanufacturing
